Special Interest Sessions

View Registration Information

Special Interest sessions provide the opportunity for ASH’s various communities to focus on specific topics of interest, ranging from coping with physician stress and burnout, to counseling fellows on careers in hematology, to the impact of ASH’s international outreach programs.

Unless otherwise noted, all sessions will take place in person and stream simultaneously on the virtual platform. Session recordings will be available on demand on the virtual platform.

Jump to:

Artificial Intelligence in Hematology: From Generative AI to Ethics and Applications

Saturday, December 7, 2024, 4:00 p.m. - 5:30 p.m.
San Diego Convention Center, Hall B

The session will address important and timely topics related to the application of artificial intelligence (AI) to hematology, ranging from generative AI's potential and pitfalls, modern ethical consideration for AI in biomedical research and examples of practical use of AI in hematology research and clinical care.

Chair:

Olivier Elemento, PhD,MS,BS
Weill Cornell Medicine
New York, NY

Speakers:

James Zou, PhD
Stanford University
Stanford, CA
The Potential and Pitfalls of Generative AI in Basic and Clinical Research

Camille Nebeker, EdD, MS
University of California San Diego
San Diego, CA
From Principles to Practice: Ensuring Ethical Integrity in AI-Driven Biomedical Research

Claudia Haferlach, MD
MLL Munich Leukemia Laboratory
Munich, Germany
The Application of Artificial Intelligence in Hematological Diagnostics

ASH Clinical Practice Guidelines on Acute Lymphoblastic Leukemia (ALL) in Adolescents and Young Adults

Sunday, December 8, 2024, 9:30 a.m. - 11:00 a.m.
Marriott Marquis San Diego Marina, Marriott Grand Ballroom 2-4

This special education session will preview recommendations for the management of both newly diagnosed and relapsed/refractory ALL in adolescents and young adults.

Chair:

Sumit Gupta, MD, PhD
Hospital for Sick Children
Toronto, ON, Canada

Speakers:

Julie Wolfson, MD, MSHS
The University of Alabama at Birmingham
Birmingham, AL
Management of Frontline ALL in AYA

Jennifer L. McNeer, MD
University of Chicago
Chicago, IL
Management of Frontline ALL in AYA

Kristen M. O'Dwyer, MD
University of Rochester
Rochester, NY
Management of Refractory and Relapse of ALL in Adolescents and Young Adults

Lena E Winestone, MD
University of California San Francisco
San Francisco, CA
Management of Refractory and Relapse of ALL in Adolescents and Young Adults

ASH Clinical Practice Guidelines on Amyloidosis

Sunday, December 8, 2024, 4:30 p.m. - 6:00 p.m.
Manchester Grand Hyatt San Diego, Grand Hall B

This session will review the scope and goals of the upcoming guidelines on amyloidosis, and will provide insights on risk factors, selecting a target site versus a surrogate site for diagnostic biopsies, and using Congo Red stain screening.

Chair:

Vishal Kukreti
University Health Network
Toronto, ON, Canada

Speakers:

Joselle Cook, MBBS
Mayo
Rochester, MN
Increasing Awareness of Risk Factors for AL Amyloidosis

Angela Dispenzieri, MD
Mayo Clinic
Rochester, MN
Target Site vs. Surrogate Site Biopsy for Diagnosis

Hira Shaikh, MD
University of Iowa Caver College of Medicine
Coralville, IA
Target Site Vs. Surrogate Site Biopsy for Diagnosis

Naresh Bumma, MD
The Ohio State University
Columbus, OH
Congo Red Stain Bone Marrow Screening for AL Amyloidosis

ASH Clinical Practice Guidelines on Pediatric Venous Thromboembolism (VTE)

Saturday, December 7, 2024, 9:30 a.m. - 11:00 a.m.
San Diego Convention Center, Room 25

This special education session will give a preview on the revision background, which includes asymptomatic VTE, duration of therapy for provoked and unprovoked VTE, and use of anticoagulants (especially DOACs) in pediatric patients.

Chair:

Paul Monagle, MD,BS,MSc,FRACP,FRCPA,MB
University of Melbourne Royal Children's Hospital
Parkville, VIC, Australia

Speakers:

Leslie Raffini, MD
Children's Hospital of Philadelphia
Philadelphia, PA
Why Revise the Guidelines?

Rukhmi Bhat, MD,MS
Lurie Children's Hospital
Chicago, IL
Asymptomatic VTE in Pediatric Patients

Marisol Betensky, MD
Johns Hopkins All Children's Hospital
Saint Petersburg, FL
Duration of Therapy for Provoked and Unprovoked VTE in Pediatric Patients

Tina Biss
The Newcastle upon Tyne Hospitals NHS Trust
Newcastle Upon Tyne, ENG, United Kingdom
Use of Anticoagulants in Children

ASH Clinicians in Practice (ACIP) Lunch - The Role of Artificial Intelligence in Hematology Practice: The Good, the Bad, and the Ugly

Sunday, December 8, 2024, 11:15 a.m. - 12:30 p.m.
Marriott Marquis San Diego Marina, Marina Ballroom DE

Artificial Intelligence (AI) has the potential to transform health care by enhancing diagnostic accuracy, predicting patient outcomes, and developing personalized treatment plans. Machine learning algorithms can analyze vast amounts of medical data, leading to more efficient and precise health care interventions, which could improve patient care and reduce costs. However, implementation of AI in health care also poses challenges related to data privacy concerns, ethical considerations, and the need for robust regulatory frameworks to ensure the responsible and secure use of sensitive medical information. In this session, panelists will speak on the recent advances and use of AI in health care, how it’s integrated into hematology practice by providers, and the use of AI by patients.

Chair:

Mary-Elizabeth M. Percival, MD
Seattle Cancer Care Alliance
Seattle, WA

Speakers:

Jim Whitfill
Honor Health
Phoenix, AZ
Artificial Intelligence in Health Care: Benefits and Pitfalls

Christopher Manz, MD, MSHP
Dana-Farber Cancer Institute
Boston, MA
Artificial Intelligence as a Clinical Tool: Hacks in Practice

Gwen L Nichols, MD
The Leukemia and Lymphoma Society
Rye Brook, NY
Patient Facing Artificial Intelligence: Uses and Ethical Implications

ASH Networking Reception for the Hemostasis and Thrombosis Community - Hosted by the Blood Vessels, Thrombosis and Hemostasis Journal

Monday, December 9, 2024, 6:00 p.m. - 7:30 p.m.
San Diego Convention Center, East Terrace (Upper Level)

ASH Quality Improvement Champions

Monday, December 9, 2024, 2:45 p.m. - 4:15 p.m.
San Diego Convention Center, Room 7

This new session merges the ASH Choosing Wisely Champions and the ASH Guideline Implementation Champions into a single, 90-minute session. Speakers will be selected from a pool of applicants. In addition to projects that combat overuse (previously the focus of the Choosing Wisely Champions session) and projects that highlight successful guideline implementation strategies (previously the focus of the Guideline Implementation Champions session), the call for applications for this session considers any quality improvement project (e.g., combating underuse, improving stewardship of resources, improving processes, reducing or eliminating healthcare disparities, etc.). The goal of this change is to expand opportunities to highlight high-quality quality improvement work while concentrating the focus into a single session.

Co-Chairs:

Ming Y Lim, MBBChir
University of Utah Health
Salt Lake Cty, UT

Rachel P. Rosovsky, MD
Massachusetts General Hospital
Boston, MA

Speakers:

Josaura Fernandez Sanchez, MD
Texas Children’s Hospital, Baylor College of Medicine
Houston, TX
Standardizing Emergency Department Management of Iron Deficiency Anemia from Heavy Menstrual Bleeding

Paolo Lopedote, MD
City of Hope National Medical Center
Monrovia, CA
Reduced Blood Transfusions in Patients with Chronic Liver Disease Undergoing Paracentesis

Asinamai M Ndai, BPharm, MS
University of Florida Health Physicians
Gainesville, FL
Optimized Management of Hemophilia in the Emergency Department

ASH Research Collaborative Data Hub Sickle Cell Disease Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation

Monday, December 9, 2024, 4:30 p.m. - 6:00 p.m.
San Diego Convention Center, Room 11

Session Description: During this 90-minute special-interest session, sickle cell disease (SCD) registry and real-world evidence (RWE) leaders will discuss progress across numerous SCD data initiatives, including the ASH Research Collaborative’s SCD Data Hub and other federal and non-federal programs. Specific topics include examples of using real-world data (RWD) to generate RWE, how RWD can be used to monitor clinical practice and outcomes for patients who receive cell and gene therapies, various approaches to ensuring data quality when using electronic health record data (EHR), federal priorities related to RWE generation that supports regulated research, and a new project to increased SCD-specific data standards within EHRs.

Co-Chairs:

Alexis Thompson, MD, MPH
Perelman School of Medicine, University of Pennsylvania
Philadelphia, PA

Ted Wun, MD
Division of Hematology and Oncology, UC Davis Comprehensive Cancer Center
Sacramento, CA

Speakers:

Alexis Thompson, MD, MPH
Children's Hospital of Philadelphia
Philadelphia, PA
Representing Sickle Cell Disease Health Concepts in Real World Evidence Generation: Examples from Real World Data (RWD) Initiatives and the Importance to the Sickle Cell Disease Community

Patty Steinert, PhD,MBA
Medical College of Wisconsin
Milwaukee, WI
The Role of RWD in Long-Term Follow-up of Cell and Gene Therapies in Sickle Cell Disease: The CIBMTR experience

Sophie Lanzkron, MD
Thomas Jefferson University
Baltimore, MD
Challenges in Data Quality: Where EHR Data Acquisition Approaches and Highly-Curated Datasets Intersect (1)

Ashima Singh, PhD,MS
Medical College of Wisconsin
Pewaukee, WI
Challenges in Data Quality: Where EHR Data Acquisition Approaches and Highly-Curated Datasets Intersect (2)

Nicole Verdun, MD
FDA
Silver Spring, MD
Regulatory Perspective: Why RWD is Critical for Evaluation of SCD Disease Modifying Curative Therapies

LaVerne Perlie, MSN, BSN, RN
Health and Human Services
Washington, DC
Bringing It All Together: How the Federal Government Is Facilitating Collaboration across the Sickle Cell Data Landscape

ASH Research Collaborative Multiple Myeloma Network: Accelerating Research and Collaborative Clinical Care through Real-World Evidence Generation

Saturday, December 7, 2024, 4:00 p.m. - 5:30 p.m.
Marriott Marquis San Diego Marina, Pacific Ballroom Salons 24-26

This 90-minute special-interest session will focus on the ASH Research Collaborative’s Multiple Myeloma Program’s efforts to accelerate research and collaborative clinical care in hematologic malignancies. Three topics will describe the ASH Research Collaborative’s approach to aggregating and visualizing real-world data (RWD) in multiple myeloma in a US-based, multi-site network; a proof-of-concept study with a hybrid decentralized workflow that was conducted in the ASH RC Myeloma Network this year; and new directions for RWD analysis in hematologic malignancies, including the use of artificial intelligence. A panel will then highlight work that is being done by the European HARMONY Alliance and other real-world data registries.

Chair:

Kenneth C. Anderson, MD
Dana-Farber Cancer Institute
Boston, MA

Speakers:

William A. Wood, MD,MPH
University of North Carolina At Chapel Hill Hospital
Chapel Hill, NC
Building a National Multiple Myeloma Data Hub to Accelerate Research and Enhance Clinical Care

Saad Z. Usmani, MD
Memorial Sloan Kettering Cancer Center
New York, NY
Working with Data Hub Data and Network PIs to Develop Evidence that Changes Practice in Multiple Myeloma: The COSMIC Study as Proof of Concept

Shaji Kumar, MD
Mayo Clinic
Rochester, MN
Pushing Data Frontiers: How Artificial Intelligence and Molecular Data can Facilitate Translational Research in the Network

Jesus Maria Hernandez Rivas, MD
University of Salamanca, IBSAL, IBMCC, CSIC
Salamanca, Spain
Panel Discussion: Real World Experience with Establishing Registries and Reporting Results (Panelist 1)

Elena Zamagni, MD
Bologna University School of Medicine
Bologna, Italy
Panel Discussion: Real World Experience with Establishing Registries and Reporting Results (Panelist 2)

Doris K. Hansen, MD
H. Lee Moffitt Cancer Center and Research Institute
Tampa, FL
Panel Discussion: Real World Experience with Establishing Registries and Reporting Results (Panelist 3)

Blood Advances Presents: How to Peer Review a Scientific Paper

Sunday, December 8, 2024, 11:15 a.m. - 12:15 p.m.
San Diego Convention Center, Room 24

Peer review plays a vital role in the dissemination and assessment of scientific research. Authors benefit from receiving an independent assessment of their work and reviewers benefit by gaining access to novel data. Dr. Catherine Bollard and Dr. Andrew Weyrich, the editor-in-chief and deputy editor for Blood Advances, will present recommended practices for reviewing a scientific paper for a peer-reviewed journal. The session will include topics such as things to consider when accepting or declining an invitation to review, how to write a review that is helpful for authors and editors, and what a reviewer should do if they suspect a possible research integrity issue. The presentation will be followed by a period for audience questions.

Panelist:

Andrew S. Weyrich, PhD
Oklahoma Medical Research Foundation
Oklahoma City, OK

Blood Presents: How to Get Published in a Peer-Reviewed Journal

Saturday, December 7, 2024, 11:15 a.m. - 12:15 p.m.
San Diego Convention Center, Room 24

Peer-reviewed journals serve a crucial role in helping researchers refine and publicize their work and helping readers sort through the ever-expanding scientific literature. Yet finding the right journal for one's research and framing data properly can be a challenge. Dr. Nancy Berliner and Dr. Andrew Roberts, the editor-in-chief and deputy editor for Blood, will present recommended practices for writing a scientific paper and submitting it to a peer-reviewed journal. The session will include topics such as how to develop the "story" for your research, how to respond to reviewer comments, and what to do when your submission is rejected. The presentation will be followed by a period for audience questions.

Panelists:

Nancy Berliner, MD
Brigham and Women's Hospital
Boston, MA

Andrew W. Roberts, MBBS,PhD
The Walter and Eliza Hall Institute of Medical Research
Parkville, VIC, Australia

Center for Sickle Cell Disease Initiatives: Advancing Progress in Sickle Cell Disease Update and Reception: hosted by ASH and ASH Research Collaborative

Monday, December 9, 2024, 6:00 p.m. - 8:00 p.m.
San Diego Convention Center, Room 11 and West Terrace

All meeting attendees interested in sickle cell disease are invited to attend the Center for Sickle Cell Disease Initiatives: Advancing Progress in Sickle Cell Disease Update and Reception. ASH is continuing its keen focus on the sickle cell disease initiative through the newly established ASH Center for Sickle Cell Disease Initiatives. This new Center will bring greater focus and cohesion to advancing our SCD initiatives. The Center is enhancing our ability to coordinate, track, and manage the wide range of responsibilities for this strategic initiative. The Center is focused on: Convening multidisciplinary partners and collaborators, promoting access to high quality care, global issues, policy and advocacy, research, and leveraging data. Please join us for an evening of networking and learn about this year's accomplishments.

DEI Community Networking Lunch (for in-person participants)

Monday, December 9, 2024, 12:00 p.m. - 1:15 p.m.
Marriott Marquis San Diego Marina, Marina Ballroom D

This is a community-building and networking event for members that fall within the diversity, equity, and inclusion (DEI) umbrella to gather and get to know each other across the varying and intersectional communities. This event is hosted by the Committee on Diversity, Equity, and Inclusion and aims to create space for ASH DEI communities and allies and, where possible, identify opportunities to learn more about the experiences and needs of these communities to allow ASH to have a greater impact in its DEI efforts. This year’s event will include inspiring remarks from a member of the committee and networking opportunities throughout.

Moderators:

Noha Soror, MD,MSc
University of Oklahoma Health Science Center
Edmond, OK

Sarwish Rafiq, PhD
Emory University School of Medicine
Atlanta, GA

Panelist:

Marcos de Lima, MD
The Ohio State University
Columbus, OH

Early Faculty Career Development Session

Monday, December 9, 2024, 10:30 a.m. - 12:00 p.m.
San Diego Convention Center, Room 25

In this Junior Faculty Career Development Session, attendees will hear a series of lectures focused on Mentorship. These didactic lectures will feature mentoring experts sharing their experiences in how to receive, provide, and optimize mentoring. Mentor/Mentee relationships can be hard to foster, and in this session, we will focus on empowering junior faculty with the tools to get the most out of this relationship. Junior faculty will hear from mentors and mentees both in the clinical and basic research fields and gain a better understanding on what it is to be a good mentor and mentee.

Co-Chairs:

Adam Scott Kittai, MD
The Ohio State University
Columbus, OH

Andrew G Volk, PhD
Cincinnati Children's Hospital Medical Center
Cincinnati, OH

Speakers:

Betty S. Pace, MD
Augusta University
Augusta, GA
Identifying a Mentor and Optimizing the Mentor/Mentee Relationship, How to be a Good Mentee?

Adam Scott Kittai, MD
The Ohio State University
Columbus, OH
Identifying a Mentor and Optimizing the Mentor/Mentee Relationship, How to be a Good Mentee?

Joseph Mikhael, MD, MeD, FRCPC, FACP
Translational Genomics Research Institute
Phoenix, AZ
The Warning Signs of a Problematic Mentoring Relationship and How to Fix it

Shannon Elf, PhD
The University of Chicago
Chicago, IL
The Warning Signs of a Problematic Mentoring Relationship and How to Fix it

Leidy Isenalumhe
Moffitt Cancer Center
Lutz, FL
Transitioning from Being a Mentee to Becoming a Mentor

Raquel Espin Palazon, PhD
Iowa State University
Ames, IA
Transitioning from Being a Mentee to Becoming a Mentor

Grassroots Network Lunch

Saturday, December 7, 2024, 11:15 a.m. - 12:15 p.m.
Marriott Marquis San Diego Marina, Marina Ballroom DE

The ASH Grassroots Network Lunch provides a forum for interested members to learn how they can participate in ASH’s advocacy efforts, communicate with Congress and their elected officials, become effective advocates for hematology, and discuss the Society’s legislative and regulatory priorities. An overview of the Society’s 2024 advocacy accomplishments and a preview of the Society’s 2025 advocacy agenda will also be provided.

Co-Chairs:

Jennifer Holter-Chakrabarty, MD
University of Oklahoma Stephenson Cancer Center
Oklahoma City, OK

Bart L. Scott, MD
Fred Hutchinson Cancer Center
Seattle, WA

Speaker:

Kirk Bado, Belmont University, Bachelor of Science in Politics and Public Law. University of North Carolina, Masters of Communication
National Journal
Washington, DC
Grassroots Network Lunch

Health Equity Rounds Lunch

Sunday, December 8, 2024, 11:30 a.m. - 12:30 p.m.
Manchester Grand Hyatt San Diego, Coronado Ballroom AB

Health Equity Rounds are interactive, case-based discussions with an interdisciplinary panel to include hematologists, health equity/public health experts, patients, and patient advocates to discuss health equity issues within hematology. Lunch will be provided to in-person attendees.

Co-Chairs:

Yvonne A. Efebera, MD
Ohio Health
Columbus, OH

Srinivas Devarakonda, MD
Ohio State University Medical Center
Columbus, OH

Speakers:

Ash Blythe Alpert, MD, MFA
Yale School of Medicine
New Haven, CT
Hematologic Aspects of Gender Affirming Care

Eric Scott Mullins, MD
Cincinnati Children's Hospital Medical Center
Cincinnati, OH
Hematologic Aspects of Gender Affirming Care

Health Equity Symposium: Race, Structural Racism and the Social Determinants of Health in Hematology

Sunday, December 8, 2024, 9:30 a.m. - 11:00 a.m.
San Diego Convention Center, Room 6DE

The misuse of race in medicine has far-reaching implications across practice, teaching, and research in hematology. This session is intended to explore what race is and what it is not, and illustrate how systemic factors, including racism, influence health care access and outcomes. The session will also explore strategies to tackle systemic racism in patient care and how to create conditions for equitable care for patients with blood diseases. Dr. Joseph L. Graves Jr. will provide a summary of the history of biological conceptions of race and describe modern evolutionary conceptions of race. He will then address how this understanding can be useful in employing the power of modern genomic tools applied to human biological diversity, including how the use of these tools completely unravels the false premises of racial medicine. Dr. Chanita Hughes Halbert will define health care disparities and describe the nature and distribution of social determinants of disparities in disease risk and outcomes. She will also provide an overview of structural racism and its impact on health care outcomes in diverse populations.

Chair:

Deirdra R Terrell, PhD
University of Oklahoma Health Sciences Center
Oklahoma City, OK

Speakers:

Joseph L Graves Jr., PhD
North Carolina A&T State University
Greensboro, NC
The Myth of Race in Medical Science

Chanita Hughes Halbert, PhD
University of Southern California
Los Angeles, CA
Structural Racism, the Social Determinants of Health, and Healthcare Outcomes – Understanding Inequity and What to Do About It

Hematology Inclusion Pathway (HIP) Networking Reception

Saturday, December 7, 2024, 8:00 p.m. - 9:00 p.m.
Marriott Marquis San Diego Marina, Marina Ballroom G

Join our HIP community to network and celebrate our awardees and their mentors at this reception following the oral presentations.

Hematology Inclusion Pathway (HIP) Oral Presentations - Classical Hematology

Saturday, December 7, 2024, 6:30 p.m. - 8:00 p.m.
Marriott Marquis San Diego Marina, Marina Ballroom E

The Hematology Inclusion Pathway Presentations and Reception (previously known as Promoting Minorities in Hematology); ASH invites all interested meeting attendees to this event, which will showcase the research of our Hematology Inclusion Pathway awardees. This initiative is a comprehensive 13-year longitudinal career pathway of awards that strives to ensure that hematology reflects and serves the diverse world we live in. The highlight of the session will be oral scientific presentations from program participants.

Moderators:

Cecelia Calhoun, MD,MBA,MPH
Yale School of Medicine
New Haven, CT

Dailia B. Francis, MD,PhD
Aflac Cancer and Blood Disorders Center at Children's Healthcare of Atlanta
Atlanta, GA

Imo J. Akpan, MD
Columbia University
New York, NY

Speakers:

Abdi Abud
University of Missouri, Columbia
Saint Louis, MO
Validation of a Natural Language Processing Tool for Identification of Acute Deep Venous Thrombosis

Valeria Brown
The Warren Alpert Medical School of Brown University
Providence, RI
Investigating the Role of Long Interspersed Element-1 (LINE-1) in Age-Related Clonal Hematopoiesis of Indeterminate Potential (CHIP) Driven By JAK2 V617F Mutation

Esther Chioma Emenalom
University of California, San Diego
San Diego, CA
A Study of Postpartum Hemorrhage and a Cryoprecipitate Intervention at Hospital Central De Maputo

Maria Fernanda Albuja Altamirano, MD
Lincoln General Hospital
New York, NY
Incidence of Thrombotic and Bleeding Complications in Patients with Cancer Undergoing Lower Extremity Arthroplasty, an Administrative Database Study

Ashley Crosby, MD
Atrium Health Wake Forest Baptist Medical Center
Winston Salem, NC
Monocyte Distribution Width As a Marker of Red Cell Alloimmunization

Ayotola A. Fatola, MD
Johns Hopkins University School of Medicine
Baltimore, MD
Evaluating the Role of Voxelotor and Percent Modified Hemoglobin (Hemoglobin X) on Laboratory and Clinical Responses in Patients with Sickle Cell Disease

Olisaemeka Ogbue, MBBS
Cleveland Clinic Foundation
Rocky River, OH
Can Emergency Hematopoiesis Due to Sepsis Lead to Clonal Hematopoiesis? Implications for Understanding the Pathogenesis of Clonal Evolution

Maria Feliz Norberto, MS
Albert Einstein College of Medicine
Bronx, NY
Heterozygous DDX41 Mutations Promote Age-Dependent Hematopoietic Stem and Progenitor Dysfunction

Conroy O Field, MS
The University of Pennsylvania School of Medicine
Philadelphia, PA
Role of Platelet Factor 4 in the Prothrombotic Nature of Antiphospholipid Syndrome

Sarah Mansour
Emory University
Atlanta, GA
Methionine Sulfoxide and Other Metabolites from Bronchoalveolar Lavage Are Associated with Neutrophil-Dominated Lung Disease in Early Cystic Fibrosis

Olufunke Y. Martin, MD
Children's National Hospital
Washington DC, DC
The Role of Red Blood Cell Vascular Adhesion Biomarkers in Understanding Sickle Cell Disease-Associated Chronic Pain

Walatta-Tseyon Mesquitta, BSc,DPhil
Boston Children's Hospital
Boston, MA
Interrogating TCF15 Function in Native Hematopoiesis Using TCF15 Overexpression and Conditional Knock out Mouse Models

Hematology Inclusion Pathway (HIP) Oral Presentations - Health Services Outcomes

Saturday, December 7, 2024, 6:30 p.m. - 8:00 p.m.
Marriott Marquis San Diego Marina, Marina Ballroom F

Moderators:

Joanna Robles, MD
Atrium Health Wake Forest Baptist Brenner Children’s Hospital
Winston Salem, NC

Oreofe O. Odejide, MD,MPH
Dana-Farber Cancer Institute
Boston, MA

Staci D. Arnold, MD, MBA, MPH
Aflac Canver and Blood Disorders Center at Children's Healthcare of Atlanta, Emory University
Atlanta,

Speakers:

Emily Franco, BA
The Warren Alpert Medical School of Brown University
Davie, FL
Exploring Mental Health in Sickle Cell Disease: Implementing Routine Psychological Assessment in a Comprehensive Sickle Cell Clinic

Rachelle Monteau
CUNY School of Medicine
New York, NY
Outcomes of Adult ALL/LBL Patients from Diverse Backgrounds Treated in the United States between 2000 and 2022

Osariemen Ogiamien
University of California Riverside Science Library
Riverside, CA
Neighborhood Socioeconomic/Environmental Disadvantage and Health Outcomes after Allogeneic Hematopoietic Cell Transplantation

Margarita Vazquez Almonte
SUNY Upstate Medical University
Bronx, NY
Parenthood While in Hematology: Perceived Barriers

Daniel Goyco Vera, MD
Baylor College of Medicine
Houston, TX
Outcomes of Patients Underrepresented in Pivotal Trials of CAR-T Cell Therapy

Michelle Nwachukwu, DO
University of Illinois at Chicago
Chicago, IL
The Impact of Structural Racism on Molecular Subtypes and Survival Outcomes in Acute Myeloid Leukemia Patients

Ifeanyi Nnamdi Uche, MBBS
One Brookdale University Hospital and Medical Center
Brooklyn, NY
Examining the Impact of Body Mass Index on Outcomes in Young Adults with Sickle Cell Disease: A Single-Center Study

Britney Bell, MD
Section of Hematology and Medical Oncology, Boston Medical Center
Boston, MA
Integration of Health Literacy Universal Precautions into Clinical Practice as a Strategy to Improve Patient-Reported Outcomes in Patients with Hematologic Malignancies and Limited English Proficiency

Eden Ayele Biltibo, MD,MS
Vanderbilt University Medical Center
Nashville, TN
Impact of Daratumumab in the Treatment of Vulnerable Transplant Eligible Multiple Myeloma Patients and Its Utilization in Blacks

Gerard Hills, MD
Riley Hospital for Children at Indiana University Health
Indianapolis, IN
A Step Toward Individualized Mortality Risk Prediction in Patients with Sickle Cell Disease in a National EHR-Derived Population Dataset

Alexandra Power-Hays, MD
Cincinnati Children's Hospital Medical Center
Cincinnati, OH
Alternative Dosing and Prevention of Transfusions (ADAPT): A Prospective Trial to Quantify the Change in Blood Transfusion Use with Hydroxyurea Treatment and the Feasibility of Pharmacokinetic-Guided Dosing in Children with Sickle Cell Anemia in Uganda

Hematology Inclusion Pathway (HIP) Oral Presentations - Malignant Hematology

Saturday, December 7, 2024, 6:30 p.m. - 8:00 p.m.
Marriott Marquis San Diego Marina, Marina Ballroom D

Moderators:

Anita D'Souza, MD
Medical College of Wisconsin
Milwaukee, WI

Jorge Monge, MD
University of Colorado Anschutz Medical Campus
Aurora, CO

Mazie Tsang, MD
Mayo Clinic
Phoenix, AZ

Speakers:

John Roy R Lozada, MD
University of Minnesota
Minneapolis, MN
An Integrated Systems Biology Approach to Understanding the Phenotypic and Functional Diversity of Natural Killer Cells in Cancer

Sofia E. Luna
Leland Stanford Stanford Junior University
Stanford, CA
Engineering Hematopoietic Stem Cells to Generate Therapeutic Antibody Secreting B Cells

Fathima Mohamed
University of Minnesota
Minneapolis, MN
Metabolic Regulation of the Germinal Center Reaction in Chronic Graft Versus Host Disease

Andres J Rubio, MS
Texas Tech University Health Sciences Center El Paso Paul L. Foster School of Medicine
El Paso, TX
A Role for PSMD3 in Regulating Oxidative Energy Metabolism in Acute Myeloid Leukemia (AML)

Catherine Gutierrez, MD, PhD
Massachusetts General Hospital
Boston, MA
Identifying Mechanisms of Resistance to ATR Inhibition in Myelodysplastic Syndromes with Splicing Factor Mutations

Kelly Meza, MD
Baylor College of Medicine
Houston, TX
Retrospective Analysis of the PET/CT Imaging Features of Peripheral T-Cell Lymphoma (PTCL) and Cutaneous T-Cell Lymphoma (CTCL) Patients

Joane Titus, MD, MS
University of Central Florida
Orlando, FL
Retrospective Review of Care for Black/African American Veterans with Multiple Myeloma at the Orlando VA

Kalay Bertulfo, MS,MA,MPhil
Columbia University Irving Medical Center
New York, NY
Therapeutic Targeting of JAK/STAT Signaling and Histone Acetyltransferase Activity in Post-Myeloproliferative Neoplasm Secondary AML

Quenton Bubb, MPhil
Leland Stanford Junior University
Stanford, CA
Development of Multivalent Cell Therapies for Treatment of Hematologic Malignancies

Joice Kanefsky
Fox Chase Cancer Center
Philadelphia, PA
Disruption of Polyunsaturated Fatty Acid Biosynthesis Drives Sting-Dependent Acute Myeloid Leukemia Cell Maturation and Death

Kristopher Adrian Knight
Emory University
Atlanta, GA
Development of a Novel L-Asparaginase with Enhanced Properties Using Ancestral Sequence Reconstruction

Owhofasa Agbedia
MD Anderson Cancer Center
houston, TX
Targeting Aggressive NK-Cell Leukemia and Other CD94-Expressing NK/T-Cell Lymphoproliferative Disorders with CAR T-Cell Therapy

LGBTQIA+ Community Networking Brunch (for in-person participants)

Sunday, December 8, 2024, 11:00 a.m. - 12:30 p.m.
Manchester Grand Hyatt San Diego, Coronado DE

This is a community-building and networking event for members of the LGBTQIA+ community attending the meeting. The event is hosted by the Committee on Diversity, Equity, and Inclusion and aims to create a sense of belonging and allyship. This year’s event will include an insightful panel discussion focused on being LGBTQIA+ across the hematology career spectrum, including the role of mentorship and the importance of inclusivity, as well as ample networking opportunities.

Moderator:

Jonas Jutzi, MD, PhD
Brigham and Women’s Hospital, Harvard Medical School
Boston,

Panelists:

Mouhamed Yazan Abou-Ismail, MD
University of Utah
Salt Lake City, UT

Diane Krause
Yale University
New Haven, CT

Medical Educators Symposium

Sunday, December 8, 2024, 7:30 a.m. - 9:30 a.m.
Marriott Marquis San Diego Marina, Marina Ballroom FG

The Medical Educators Symposium (previously called the Hematology Course Directors Workshop) is open to all medical educators across the medical student, resident, and fellow continuum. The Medical Educators Symposium highlights cutting edge teaching techniques and theories while also showcasing participants of the ASH Medical Educators Institute. The symposium is two hours long and will begin with an hour of general sessions focused on medical education principles and then followed by simultaneous breakout sessions that happen twice.

Chair:

Hetty E. Carraway, MD,MBA
Cleveland Clinic
Cleveland, OH

Speakers:

Alison Loren, MD
University of Pennsylvania
Philadelphia, PA
General Session 1: Paving a Career in Medical Education & Scholarship

Megan Murray Dupuis, MD, PhD
Vanderbilt University Medical Center
Nashville, TN
General Session 2: Utilizing Humanities to Influence and Tailor Hematology Curriculum for Adult Learners

Layla Van Doren
Yale University
New York, NY
General Session 3: Incorporating Health Equity Education in UME/GME Curriculum

Alexander A Boucher, MD
University of Minnesota
Minneapolis, MN
General Session 3: Incorporating Health Equity Education in UME/GME Curriculum

Beverly Schaefer, MD
University of Buffalo
Buffalo, NY
Breakout 1: Challenges of Course Development

Ariela L. Marshall, MD
University of Minnesota
Rochester, MN
Breakout 2: Developing Your Teaching Portfolio

Jason A Freed, MD
Beth Israel Deaconess
Boston, MA
Breakout 3: Cutting-Edge Technology in Education Delivery

Thomas W. LeBlanc, MD,MA,MS
Duke Cancer Institute
Hillsborough, NC
Breakout 4: Developing a Palliative Care/Difficult Discussion Curriculum

Race and Ancestry in Precision Medicine

Sunday, December 8, 2024, 4:30 p.m. - 5:45 p.m.
San Diego Convention Center, Room 6DE

Race and ancestry, historically, have been poorly considered in basic and translational research design and clinical diagnoses. This session will describe how race and ancestry can inform hematology research conduct, specifically in clinical and genetic population profiling, interpretation of common hematologic tests, development of diagnostics, and overall precision medicine. The speakers selected in this session have incorporated race and ancestry in their own research and will be sharing their insights to help educate hematology investigators and clinicians understand how to consider race and ancestry into their own research and practice.

Dr. Fox will discuss the intersection between human population genetics, biomedicine, ancient genomics, and Indigenous data sovereignty. This talk will provide perspectives on why community consultation matters in genomics research and in the establishment of benefit-sharing models.

Dr. Eisfeld will discuss race-associated differences in the mutational landscape and the prognostic significance of molecular markers in acute myeloid leukemia (AML) in Black patients. This talk will highlight the need for refinement of disease classification and molecular subtypes to enable personalized risk-stratification and treatment options for racially diverse populations.

Dr. Achebe has led the hematology community in incorporating Duffy-null status into clinical algorithms to improve health equity for Duffy-null individuals among Black and African American adults. This talk will highlight how inappropriate blood count reference ranges can propagate systemic racism.

Co-Chairs:

Jennifer J. Trowbridge, PhD
The Jackson Laboratory
Bar Harbor, ME

Sant-Rayn Pasricha, MD,PhD
Walter and Eliza Hall Institute of Medical Research
Fitzroy North, VIC, Australia

Speakers:

Keolu Fox
University of California, San Diego
San Diego, CA
Incorporating Indigenous Perspectives into Population Genetics

Ann-Kathrin Eisfeld, MD
The Ohio State University
Columbus, OH
Risk Re-Stratification Based on Black AML Patient Exome Data

Maureen Achebe
Brigham and Women's Hospital
Boston, MA
How Inappropriate Reference Ranges Can Propagate Systemic Racism

Sickle Cell Disease Centers Session

The Role of Quality Metrics in Demonstrating Value of Your Sickle Cell Disease Center

Sunday, December 8, 2024, 9:30 a.m. - 11:00 a.m.
San Diego Convention Center, Room 33

To ensure high-quality care for patients with sickle cell disease (SCD), it is imperative that providers and SCD care leaders have the tools to establish comprehensive clinical care centers for patients with SCD. Over the last several years, ASH has developed a program and blueprint for the creation of sickle cell disease centers. This special interest session is designed to help sickle cell disease care centers understand the development of CMS quality metrics and how to leverage these metrics to support delivery of high-quality care.

Co-Chairs:

Sophie Lanzkron, MD
Sidney Kimmel College of Medicine, Thomas Jefferson University
Philadelphia, PA

Cecelia Calhoun, MD,MBA,MPH
Yale New Haven Hospital
New Haven, CT

Speakers:

Alexandra Power-Hays, MD
Cincinnati Children's Hospital
Cincinnati, OH
The Importance of Recognition of Pediatric Quality Metrics in SCD: The Role of US News and World Report

Titilope Fasipe, MD,PhD
Texas Children's Cancer and Hematology Centers
Houston, TX
The Creation of CMS Quality Metrics in the Treatment of Painful Episodes in the Emergency Department

Cecelia Calhoun, MD,MBA,MPH
Yale New Haven Hospital
New Haven, CT
Leveraging Quality Metrics to Maintain Support of Your Sickle Cell Disease Center

Simulcast of Announcement of Awards and Plenary Scientific Session (for in-person participants)

Sunday, December 8, 2024, 1:30 p.m. - 4:00 p.m.
San Diego Convention Center, Room 6A

Simulcast of Announcement of Awards and Plenary Scientific Session (for in-person participants)

Sunday, December 8, 2024, 1:30 p.m. - 4:00 p.m.
San Diego Convention Center, Room 28 A-D

Simulcast of Announcement of Awards and Plenary Scientific Session (for in-person participants)

Sunday, December 8, 2024, 1:30 p.m. - 4:00 p.m.
Marriott Marquis San Diego Marina, San Diego Ballroom AB

Simulcast of Announcement of Awards and Plenary Scientific Session (for in-person participants)

Sunday, December 8, 2024, 1:30 p.m. - 4:00 p.m.
Manchester Grand Hyatt San Diego, Grand Hall B

Symposium for Mid-Career Hematologists

Sunday, December 8, 2024, 4:30 p.m. - 6:00 p.m.
San Diego Convention Center, Room 24

This symposium aims to guide the audience through the common challenges faced by mid-career hematologists. Some examples of unique challenges for mid-career hematologists include negotiating the first leadership position, principles of leadership, promotion, strategies for managing individuals and teams, conflict management, setting up a successful research program, time management, funding beyond career development awards, performance and compensation metrics, self-care and opportunities to contribute to the Society’s mission. Speakers will include a diverse pool of successful physicians and scientists from academia, regulatory agencies, and the pharmaceutical industry. It is envisioned that this educational session will be organized by a steering committee of Society members who will identify a longitudinal curriculum for the session and speakers and topics.

Chairs:

Juan Pablo Alderuccio, MD
Sylvester Comprehensive Cancer Center University of Miami
Miami, FL

Shruti Chaturvedi, MBBS
Johns Hopkins University
Baltimore, MD

Speakers:

Ruben A. Mesa, MD
Atrium Health Wake Forest Baptist
Winston-Salem, NC
Negotiating Your First Leadership Position

Allison A. King, MD,PhD,MPH
Washington University School of Medicine
Saint Louis, MO
Negotiating Your First Leadership Position

Robert F. Sidonio, Jr., MD, MSc
Emory University
Atlanta, GA
Your Next Job - How to Identify Academic Opportunities with the Best Payback

Jeffrey D Lebensburger, DO
University of Alabama at Birmingham
Birmingham, AL
Your Next Job - How to Identify Academic Opportunities with the Best Payback

Nina Shah, MD
AstraZeneca
South San Francisco, CA
Making the Jump - Careers Outside Academia

David P. Steensma, MD, FACP
Ajax Therapeutics
Lincoln, MA
Making the Jump - Careers Outside Academia

Symposium on Quality: Treating Fairly - The Role of Quality Improvement in Combating Health Care Disparities

Saturday, December 7, 2024, 2:00 p.m. - 3:30 p.m.
San Diego Convention Center, Room 11

This year's Quality Symposium will focus on practical strategies for combatting healthcare disparities. First, Dr. Melissa Creary will discuss the Michigan Social Health Interventions to Eliminate Disparities (MSHIELD) program, a statewide data-driven, community-partnered, and equity-centered quality improvement effort. Then Dr. Michelle Sholzberg will review the development and impact of the "Raise the Bar" project, which aims to eliminate disparities in the recognition and management of iron deficiency by adjusting reference ranges. The session will conclude with a talk by Dr. Thomas Greg Knight on mitigating the impact of financial toxicity in patients with hematologic malignancies.

Co-Chairs:

Angela C Weyand, MD
University of Michigan
Ann Arbor, MI

Adam Cuker, MD, MS
University of Pennsylvania
Philadelphia, PA

Speakers:

Melissa Creary
University of Michigan School of Public Health
Ann Arbor, MI
MSHIELD: A Statewide Approach to Improving Equity Centered Quality Improvement

Michelle Sholzberg, MDCM, MSc
University of Toronto
Toronto, ON, Canada
Raise the Bar - Combatting Disparities in the Recognition and Management of Iron Deficiency

Thomas G. Knight, MD
Atrium Health
Charlotte, NC
Cancer and Poverty - Mitigating the Impact of Financial Toxicity in Patients with Hematologic Malignancies

Systems-Based Hematology Education and Networking Session: Anticoagulation Stewardship and AI-Assisted Management

Sunday, December 8, 2024, 4:30 p.m. - 6:30 p.m.
San Diego Convention Center, Room 25

This session will feature two talks on systems-level approaches to anticoagulation management, followed by a networking session where attendees will meet with the speakers and with established systems-based hematologists over light hors d'oeuvres and drinks. The first talk with feature Dr. Greg Barnes discussing how to improve systems-level management of anticoagulants within and across care settings. For the second talk, Dr. Damon E. Houghton will discuss the use of artificial intelligence (AI) and machine learning (ML) in the context of anticoagulation management.

Chair:

Camila Masias, MD,MPH
Miami Cancer Institute
Miami, FL

Speakers:

Geoffrey D Barnes, MD, MSc
University of Michigan
Ann Arbor, MI
Improving Systems-Level Management of Anticoagulants Within and Across Care Settings

Damon E. Houghton, MD,MS
Mayo Clinic Rochester
Rochester, MN
Artificial Intelligence (AI) and Machine Learning (ML) in the Context of Anticoagulation Management

Training Program Directors Workshop

Friday, December 6, 2024, 9:00 a.m. - 12:00 p.m.
Hilton San Diego Bayfront, Indigo 204

The Training Program Director’s Workshop is held each year before the ASH annual meeting and is designed for training program directors, associate program directors, and others involved with hematology training. The workshop is designed for hematology program directors to share lessons learned, best practice, and explore opportunities to improve their leadership skills. Through experiential learning techniques, breakout sessions, and interactive lectures, program directors can learn from peers and build their network. At this year’s TPDW, we will focus on three opportune topics. First, we will discuss how to design and implement innovative curriculums which can prepare trainees to excel at various aspects of hematology oncology practice beyond just knowledge of the subject matter. Examples of such curriculums include ‘leadership training’, ‘how to be a good educator’, and ‘business of hematology-oncology’. Second, we will focus on best practices for a training program to leverage social media and build their ‘brand’. Lastly, we will discuss practical ways in which programs can help trainees land their dream job.

Chair:

Pallawi Torka
Roswell Park Cancer Center
Buffalo, NY

Speakers:

Scott Moerdler, MD
Rutgers Cancer Institute
New Brunswick, NJ
Innovative Fellowship Curriculum

Layla N Van Doren, MD, MBA
Yale School of Medicine
New Haven, CT
Innovative Fellowship Curriculum

Angela C Weyand, MD
University of Michigan
Ann Arbor, MI
Leveraging and Enriching Social Media

Gerald Hsu, MD,PhD
University of California, San Francisco
San Francisco, CA
Best Practices to Support Fellows in the Job Search

Sunandana Chandra, MD
Northwestern University
Chicago, IL
Best Practices to Support Fellows in the Job Search

Women In Hematology Networking Event (for in-person participants)

Monday, December 9, 2024, 7:30 p.m. - 9:30 p.m.
Manchester Grand Hyatt San Diego, Coronado Ballroom and Terrace

This popular annual networking event will provide a space where all can gather and connect with peers and potential mentors. The event includes a panel discussion focused on work life integration through a gender and career development lens. Hors d'oeuvres will be provided before and after the panel, along with desserts after the panel.

Moderators:

Bethany Samuelson Bannow, MD
Oregon Health and Science University
Portland, OR

Glaivy Batsuli, MD
Stanford University
Stanford, CA

66th ASH Annual Meeting and exposition

Registration for ASH members, non-members, groups, exhibitors, and media is now open!